NURPF

NEUREN PHARMS LTD ORD by Neuren Pharmaceuticals Ltd. (NURPF)

About NEUREN PHARMS LTD ORD by Neuren Pharmaceuticals Ltd. (NURPF)

Neuren Pharmaceuticals Ltd. engages in the development of new therapies for neurodevelopmental disorders that emerge in early childhood. It operates through the Commercial Products, and Research and Development segments. The Commercial Products segment refers to the milestone and royalty revenue from license of intellectual property. The Research and Development segment focuses on the development of pharmaceutical products for the treatment of neurodevelopmental disorders. The company was founded on December 17, 2001 and is headquartered in Camberwell, Australia.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$14.80
52 Week Low
$6.60
Market cap
1.6B
Dividend yield
0.00%
Volume
--
Avg. volume
278
P/E ratio
16.76

NEUREN PHARMS LTD ORD by Neuren Pharmaceuticals Ltd. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$14.80
52 Week Low
$6.60
Market cap
1.6B
Dividend yield
0.00%
Volume
--
Avg. volume
278
P/E ratio
16.76